A Study to compare Shatpushpa Kalp and Lekhan Basti results in patient of Polycystic Ovarian Syndrome

A Comparative Clinical Study To Evaluate The Efficacy Of Shatpushpa Kalp orally And Lekhan Basti In The Management of Polycystic Ovarian Syndrome(PCOS) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073389

Enrollment

Registered

2024-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Females who are in age group 18-40yrs. Patients who are willing for the trial. Patients having menstrual irregularities in terms of flow, duration and interval. Patient having Polycystic ovaries diagnosed by USG. Patients showing other symptoms of PCOS i.e. facial hairs, acne, obesity, scalp hair loss etc. .

Exclusion criteria

Exclusion criteria: Patients of age below 18 and above 40 yrs of age. Patients having any genetic or congenital deformities or having any other disease causing oligomenorrhoea and anovulation. Any organic lesions of reproductive tract like TB, carcinoma or any other pelvic pathology. Patients suffering from systemic disorders like hypertension, diabetes, hyperprolactinemia, adrenal hyperplasia, thyroid abnormalities, cardiac diseases etc. Patients having amenorrhoea for more than 3 months. Current or previous (within last 3 months) use of OC Pills, Gluco-corticoids, anti-androgens, ovulation induction agents, anti diabetic, anti-obesity drugs, or other hormonal drug. Pregnancy, Post Menopausal stage, history of Septic abortion.

Design outcomes

Primary

Measure	Time frame
SUBJECTIVE PARAMETERS Improvement in menstrual irregularities in terms of interval duration amount of bleeding pain. OBJECTIVE PARAMETERS Reduction in BMI Improvement in hormonal assay Change in Ovarian size , volume, stromal patternTimepoint: Before Trial, Once Every month for three months, After trial	—

Secondary

Measure	Time frame
For assessmentof Bloating of abdomen Assessment of obesity on basis of BMI Assessment of obesity on basis of waist to hip ratio Assessment of acne Assessment for hirsuitism ( Ferryman Gallwey scoring) Assessment of dyspareunia Assessment of headache Assesment of depression Assessment of sleep disturbance Assessment of loss of confidence Assessment of forgetfullness Assessment of decresed libido Assessment of alopecia Assessment of psychology( irritability) Timepoint: Before Trial, Once Every month for three months, After trial	—

Measure

Time frame

For assessmentof Bloating of abdomen Assessment of obesity on basis of BMI Assessment of obesity on basis of waist to hip ratio Assessment of acne Assessment for hirsuitism ( Ferryman Gallwey scoring) Assessment of dyspareunia Assessment of headache Assesment of depression Assessment of sleep disturbance Assessment of loss of confidence Assessment of forgetfullness Assessment of decresed libido Assessment of alopecia Assessment of psychology( irritability) Timepoint: Before Trial, Once Every month for three months, After trial

—

Countries

India

Contacts

Public ContactSantvana

State Ayurvedic College And Hospital, Lucknow

drshikhasharma1982@gmail.com8743976379

Outcome results